463. Deputy David Cullinane asked the Minister for Health the steps her Department is taking to assess and mitigate the impact of the US most-favoured-nation pharmaceutical pricing policy and related trade tariffs on patient access to innovative medicines and the competitiveness of the Irish pharmaceutical sector; the status of the planned inter-departmental or sectoral taskforce established to address these global pricing shifts; when this taskforce is expected to convene; the stakeholders that will be represented; and if she will make a statement on the matter. [46472/26]

Summary

463. Deputy David Cullinane asked the Minister for Health the steps her Department is taking to assess and mitigate the impact of the US most-favoured-nation pharmaceutical pricing policy and related trade tariffs on patient access to innovative medicines and the competitiveness of the Irish pharmaceutical sector; the status of the planned inter-departmental or sectoral taskforce established to address these global pricing shifts; when this taskforce is expected to convene; the stakeholders that will be represented; and if she will make a statement on the matter. [46472/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Healthcare Policy

  xml · EN · 18 June 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.